Key facts
- Wellinks’s last known valuation is $65.0M (Nov 2021).
- It has raised $8.9M across 1 recorded rounds; the latest was Seed Round ($795K) in Sep 2016.
- Notable investors include MedTech Innovator, HighCape Capital.
- Wellinks has filed 3 Form Ds with the SEC since 2016, most recently Jul 2018 ($50K sold to 1 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Wellinks
Funding rounds
1 roundsAbout Wellinks
Provider of a virtual pulmonary care service intended to serve people with chronic respiratory disease, especially chronic obstructive pulmonary disease. The company specializes in virtual pulmonary rehabilitation, personalized health coaching and care management, remote monitoring via connected health devices and patient app, and continuous data-driven cardiopulmonary care, thereby helping clients manage their respiratory condition from home with ongoing support, improved access to care, and potential reduction in hospital visits.
- Sector
- Healthcare
- HQ
- New Haven, CT, United States
- Founded
- 2012
- Employees
- 29
- Website
- wellinks.com/
- Ownership
- Privately Held (backing)
Wellinks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wellinks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wellinks in its N-PORT filings yet. We sweep new filings monthly.